New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how much scarring occurs following kidney injury, leading scientists to identify a potential precision ...
Apr 9, 2025
0
14
Kidneys are the most transplanted organ in Germany. According to the German Organ Transplantation Foundation, a total of 1,514 kidneys were transplanted after post-mortem organ donation in 2023, out of a total of 2,986 transplanted ...
Apr 7, 2025
0
0
Johns Hopkins University-led research has found that obesity, particularly severe obesity, is strongly associated with the incidence of 16 common health outcomes. Associations remained consistent across sex and racial groups. ...
Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective means to grow iPS cell-derived kidney progenitor cells, paving the way for renal regenerative therapies ...
Apr 3, 2025
0
0
Age-related brain diseases such as stroke, dementia, and late-life depression are a debilitating part of growing older, but people can lower their risk of these diseases through behavioral and lifestyle changes.
Apr 3, 2025
0
0
Research led by Children's Hospital of Fudan University in China has found that a gene called pancreatic progenitor cell differentiation and proliferation factor (PPDPF) helps protect kidney cells by supporting enzymes involved ...
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured clinical ...
Mar 31, 2025
0
3
A new consensus paper provides an updated evaluation of reference bone turnover markers (BTMs) and newer markers in the diagnosis and management of osteoporosis.
Mar 31, 2025
0
0
For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people who have it are formally diagnosed.
Mar 31, 2025
0
0
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and type 2 diabetes in the first-of-its kind trial to evaluate ...
Mar 31, 2025
0
0
